Press Releases News Year None202020192018201720162015201420132012 IVERIC bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Mar 03, 2020 | IVERIC bio Reports Fourth Quarter and Year End 2019 Operational Highlights and Financial Results Feb 27, 2020 | IVERIC bio to Present at the Cowen and Company 40th Annual Health Care Conference Feb 26, 2020 | IVERIC bio to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on Thursday, February 27, 2020 Feb 20, 2020 | IVERIC bio Announces Design for Second Pivotal Clinical Trial of Zimura® in Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration Jan 13, 2020 | IVERIC bio to Host an R&D Investor Symposium on Tuesday, January 14, 2020 in San Francisco, CA Dec 19, 2019 | IVERIC bio to Present at the 38th Annual J.P. Morgan Healthcare Conference Dec 19, 2019 | IVERIC bio, Inc. Announces Pricing of Public Offering of Common Stock Dec 06, 2019 | IVERIC bio, Inc. Announces Proposed Offering of Common Stock Dec 05, 2019 | IVERIC bio to Present at Evercore ISI 2nd Annual HealthCONx Conference Nov 26, 2019 | Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
IVERIC bio Reports Fourth Quarter and Year End 2019 Operational Highlights and Financial Results Feb 27, 2020 |
IVERIC bio to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on Thursday, February 27, 2020 Feb 20, 2020 |
IVERIC bio Announces Design for Second Pivotal Clinical Trial of Zimura® in Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration Jan 13, 2020 |
IVERIC bio to Host an R&D Investor Symposium on Tuesday, January 14, 2020 in San Francisco, CA Dec 19, 2019 |
Press Releases News Year None202020192018201720162015201420132012 IVERIC bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Mar 03, 2020 | IVERIC bio Reports Fourth Quarter and Year End 2019 Operational Highlights and Financial Results Feb 27, 2020 | IVERIC bio to Present at the Cowen and Company 40th Annual Health Care Conference Feb 26, 2020 | IVERIC bio to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on Thursday, February 27, 2020 Feb 20, 2020 | IVERIC bio Announces Design for Second Pivotal Clinical Trial of Zimura® in Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration Jan 13, 2020 | IVERIC bio to Host an R&D Investor Symposium on Tuesday, January 14, 2020 in San Francisco, CA Dec 19, 2019 | IVERIC bio to Present at the 38th Annual J.P. Morgan Healthcare Conference Dec 19, 2019 | IVERIC bio, Inc. Announces Pricing of Public Offering of Common Stock Dec 06, 2019 | IVERIC bio, Inc. Announces Proposed Offering of Common Stock Dec 05, 2019 | IVERIC bio to Present at Evercore ISI 2nd Annual HealthCONx Conference Nov 26, 2019 | Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
IVERIC bio Reports Fourth Quarter and Year End 2019 Operational Highlights and Financial Results Feb 27, 2020 |
IVERIC bio to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on Thursday, February 27, 2020 Feb 20, 2020 |
IVERIC bio Announces Design for Second Pivotal Clinical Trial of Zimura® in Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration Jan 13, 2020 |
IVERIC bio to Host an R&D Investor Symposium on Tuesday, January 14, 2020 in San Francisco, CA Dec 19, 2019 |
